GRAS Notices
-
GRN No. 455
Bifidobacterium breve M-16V
Intended Use: | As an ingredient in exempt term powdered amino acid-based formulas, at levels providing 108 colony forming units per gram of infant formula powder |
---|---|
Basis: | Scientific procedures |
Notifier: | Danone Trading B.V. |
Notifier Address: |
Schiphol Boulevard 105 1118 BG Schiphol Airport THE NETHERLANDS |
Date of filing: | Jan 23, 2013 |
GRAS Notice (releasable information): | GRN 455 (in PDF) (15.1 MB) |
Date of closure: | Sep 30, 2013 |
FDA's Letter: | FDA has no questions |
-